Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2019

01-11-2019 | Solid Tumor | Epidemiology

Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study

Authors: Mathilde Gottschau, Allan Jensen, Kristian Reinholdt, Sonia Guleria, Christian Munk, Lene Mellemkjær, Susanne K. Kjær

Published in: Breast Cancer Research and Treatment | Issue 1/2019

Login to get access

Abstract

Purpose

To assess the association between benign ovarian tumors and subsequent risk of breast cancer, and to examine this association according to type of benign ovarian tumors.

Methods

This nationwide cohort study comprised all Danish women diagnosed with a benign ovarian tumor during 1978–2016 (n = 158,221) identified through the Danish National Patient Register. The cohort was linked to the Danish Cancer Registry to identify all cases of breast cancer, and standardized incidence ratios (SIR) and 95% confidence intervals (CI) were calculated.

Results

Overall, women with a benign ovarian tumor were at significantly increased risk of breast cancer. The risk was confined to women with a solid ovarian tumor (SIR 1.09; 95% CI 1.05–1.13), particularly in women ≥ 50 years at benign tumor diagnosis (SIR 1.19; 95% CI 1.12–1.26). The risk remained increased up to 20 years or more after the diagnosis of a solid ovarian tumor (SIR 1.11; 95% CI 1.04–1.18), and women with a solid tumor were at increased risk of ductal, lobular, and other types of breast cancer, although most consistent for the lobular subtype. For cystic tumors, this association was confined to ductal breast cancer in women with the tumor diagnosed at age ≥ 50 years.

Conclusions

Women with a benign ovarian tumor were at increased risk of breast cancer. This association was largely confined to women with a solid ovarian tumor, and the excess risk was present 20 years or more after the ovarian tumor diagnosis. The underlying mechanism is unknown and should be investigated further.
Literature
2.
go back to reference Engholm G, Ferlay J, Christensen N, Hansen H L, Hertzum-Larsen R, Johannesen T B, et al NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries, Danish Cancer Society. http://www.ancr.nu. Accessed 12 Dec 2018 Engholm G, Ferlay J, Christensen N, Hansen H L, Hertzum-Larsen R, Johannesen T B, et al NORDCAN: cancer incidence, mortality, prevalence and survival in the Nordic Countries, Version 8.1 (28.06.2018). Association of the Nordic Cancer Registries, Danish Cancer Society. http://​www.​ancr.​nu. Accessed 12 Dec 2018
3.
go back to reference Jensen MB, Ejlertsen B, Mouridsen HT, Christiansen P, for the Danish Breast Cancer Cooperative Group (2016) Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment. Acta Oncol 55(Suppl 2):24–35 Jensen MB, Ejlertsen B, Mouridsen HT, Christiansen P, for the Danish Breast Cancer Cooperative Group (2016) Improvements in breast cancer survival between 1995 and 2012 in Denmark: the importance of earlier diagnosis and adjuvant treatment. Acta Oncol 55(Suppl 2):24–35
4.
go back to reference Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev 15(10):1899–1905CrossRef Anderson WF, Pfeiffer RM, Dores GM, Sherman ME (2006) Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomark Prev 15(10):1899–1905CrossRef
5.
go back to reference McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases: breast cancer—epidemiology, risk factors and genetics. BMJ 321(7261):624–628CrossRef McPherson K, Steel CM, Dixon JM (2000) ABC of breast diseases: breast cancer—epidemiology, risk factors and genetics. BMJ 321(7261):624–628CrossRef
6.
go back to reference Dossus L, Benusiglio PR (2015) Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 17:37CrossRef Dossus L, Benusiglio PR (2015) Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res 17:37CrossRef
7.
go back to reference McDonald JM, Modesitt SC (2006) The incidental postmenopausal adnexal mass. Clin Obstet Gynecol 49(3):506–516CrossRef McDonald JM, Modesitt SC (2006) The incidental postmenopausal adnexal mass. Clin Obstet Gynecol 49(3):506–516CrossRef
8.
go back to reference Booth M, Beral V, Maconochie N, Carpenter L, Scott C (1992) A case-control study of benign ovarian tumours. J Epidemiol Community Health 46:528–531CrossRef Booth M, Beral V, Maconochie N, Carpenter L, Scott C (1992) A case-control study of benign ovarian tumours. J Epidemiol Community Health 46:528–531CrossRef
9.
go back to reference Greenlee RT, Kessel B, Williams CR, Riley TL, Ragard LR, Hartge P et al (2010) Prevalence, incidence and natural history of simple ovarian cysts among women over age 55 in a large cancer screening trial. Am J Obstet Gynecol 202(4):373CrossRef Greenlee RT, Kessel B, Williams CR, Riley TL, Ragard LR, Hartge P et al (2010) Prevalence, incidence and natural history of simple ovarian cysts among women over age 55 in a large cancer screening trial. Am J Obstet Gynecol 202(4):373CrossRef
10.
go back to reference Christensen JT, Boldsen JL, Westergaard JG (2002) Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 66(3):153–157CrossRef Christensen JT, Boldsen JL, Westergaard JG (2002) Functional ovarian cysts in premenopausal and gynecologically healthy women. Contraception 66(3):153–157CrossRef
11.
go back to reference Parazzini F, Moroni S, Negri E, Crosignani PG (1996) Risk factors for seromucinous benign ovarian cysts in northern Italy. J Epidemiol Community Health 51:449–452CrossRef Parazzini F, Moroni S, Negri E, Crosignani PG (1996) Risk factors for seromucinous benign ovarian cysts in northern Italy. J Epidemiol Community Health 51:449–452CrossRef
12.
go back to reference Parazzini F, Moroni S, Negri E, La Vecchia C, Dal Pino D, Ricci E (1996) Risk factors for functional ovarian cysts. Epidemiology 7(5):547–549CrossRef Parazzini F, Moroni S, Negri E, La Vecchia C, Dal Pino D, Ricci E (1996) Risk factors for functional ovarian cysts. Epidemiology 7(5):547–549CrossRef
13.
go back to reference Sharma A, Gentry-Maharaj A, Burnell M, Fourkala E, Campbell S, Amso N et al (2012) Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK collaborative trial of ovarian cancer screening (UKCTOCS): a prospective cohort study. BJOG 119(2):207–219CrossRef Sharma A, Gentry-Maharaj A, Burnell M, Fourkala E, Campbell S, Amso N et al (2012) Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK collaborative trial of ovarian cancer screening (UKCTOCS): a prospective cohort study. BJOG 119(2):207–219CrossRef
14.
go back to reference Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83:395–400CrossRef Borgfeldt C, Andolf E (2004) Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis. Acta Obstet Gynecol Scand 83:395–400CrossRef
15.
go back to reference Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26(7):781–785CrossRef Franceschi S, La Vecchia C, Negri E, Parazzini F, Boyle P (1990) Breast cancer risk and history of selected medical conditions linked with female hormones. Eur J Cancer 26(7):781–785CrossRef
16.
go back to reference Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70:150–154CrossRef Schairer C, Persson I, Falkeborn M, Naessen T, Troisi R, Brinton LA (1997) Breast cancer risk associated with gynecologic surgery and indications for such surgery. Int J Cancer 70:150–154CrossRef
17.
go back to reference Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22(6):1000–1009CrossRef Moseson M, Koenig KL, Shore RE, Pasternack BS (1993) The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22(6):1000–1009CrossRef
18.
go back to reference Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L et al (2008) Ovarian cysts and breast cancer: results from the Women’s Contraceptive and Reproductive Experiences Study. Breast Cancer Res Treat 109(1):157–164CrossRef Knight JA, Lesosky M, Blackmore KM, Voigt LF, Holt VL, Bernstein L et al (2008) Ovarian cysts and breast cancer: results from the Women’s Contraceptive and Reproductive Experiences Study. Breast Cancer Res Treat 109(1):157–164CrossRef
19.
go back to reference Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ et al (2006) An inverse association between ovarian cysts and breast cancer in the Breast Cancer Family Registry. Int J Cancer 118(1):197–202CrossRef Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ et al (2006) An inverse association between ovarian cysts and breast cancer in the Breast Cancer Family Registry. Int J Cancer 118(1):197–202CrossRef
20.
go back to reference Bosetti C, Scotti L, Negri E, Talamini R, Levi F, Franceschi S et al (2006) Benign ovarian cysts and breast cancer risk. Int J Cancer 119(7):1679–1682CrossRef Bosetti C, Scotti L, Negri E, Talamini R, Levi F, Franceschi S et al (2006) Benign ovarian cysts and breast cancer risk. Int J Cancer 119(7):1679–1682CrossRef
21.
go back to reference Talamini R, Franceschi S, Favero A, Negri E, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75(11):1699–1703CrossRef Talamini R, Franceschi S, Favero A, Negri E, La Vecchia C (1997) Selected medical conditions and risk of breast cancer. Br J Cancer 75(11):1699–1703CrossRef
22.
go back to reference Jung SJ, Song M, Choi JY, Song N, Park SK, Yoo KY et al (2013) Association of selected medical conditions with breast cancer risk in Korea. J Prev Med Public Health 46(6):346–352CrossRef Jung SJ, Song M, Choi JY, Song N, Park SK, Yoo KY et al (2013) Association of selected medical conditions with breast cancer risk in Korea. J Prev Med Public Health 46(6):346–352CrossRef
23.
go back to reference Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD et al (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28:816–823CrossRef Weiss HA, Brinton LA, Potischman NA, Brogan D, Coates RJ, Gammon MD et al (1999) Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28:816–823CrossRef
24.
go back to reference Lynge E, Sandegaard JL, Rebolj M (2011) The Danish national patient register. Scand J Public Health 39(7 Suppl):30–33CrossRef Lynge E, Sandegaard JL, Rebolj M (2011) The Danish national patient register. Scand J Public Health 39(7 Suppl):30–33CrossRef
25.
go back to reference Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(7 Suppl):22–25CrossRef Pedersen CB (2011) The Danish civil registration system. Scand J Public Health 39(7 Suppl):22–25CrossRef
26.
go back to reference Gjerstorff ML (2011) The Danish cancer registry. Scand J Public Health 39(7 Suppl):42–45CrossRef Gjerstorff ML (2011) The Danish cancer registry. Scand J Public Health 39(7 Suppl):42–45CrossRef
27.
go back to reference Ressing M, Blettner M, Klug SJ (2010) Data analysis of epidemiological studies: part 11 of a series on evaluation of scientific publications. Dtsch Arztebl Int 107(11):187–192PubMedPubMedCentral Ressing M, Blettner M, Klug SJ (2010) Data analysis of epidemiological studies: part 11 of a series on evaluation of scientific publications. Dtsch Arztebl Int 107(11):187–192PubMedPubMedCentral
28.
go back to reference Breslow NE, Day NE (1987) Rates and rate standardization. Statistical methods in cancer research—volume II: the design and analysis of cohort studies. IARC Scientific Publications No 82. International Agency for Research on Cancer, pp 48–79 Breslow NE, Day NE (1987) Rates and rate standardization. Statistical methods in cancer research—volume II: the design and analysis of cohort studies. IARC Scientific Publications No 82. International Agency for Research on Cancer, pp 48–79
29.
go back to reference Soegaard M, Kjaer SK, Cox M, Wozniak E, Hogdall E, Hogdall C et al (2008) BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res 14(12):3761–3767CrossRef Soegaard M, Kjaer SK, Cox M, Wozniak E, Hogdall E, Hogdall C et al (2008) BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark. Clin Cancer Res 14(12):3761–3767CrossRef
30.
go back to reference Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93(16):1215–1223CrossRef Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A (2001) Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst 93(16):1215–1223CrossRef
31.
32.
go back to reference Barry JA, Azizia MM, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748–758CrossRef Barry JA, Azizia MM, Hardiman PJ (2014) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update 20(5):748–758CrossRef
33.
go back to reference Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L (2015) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol 136(1):99–103CrossRef Gottschau M, Kjaer SK, Jensen A, Munk C, Mellemkjaer L (2015) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study. Gynecol Oncol 136(1):99–103CrossRef
34.
go back to reference Metindir J, Aslan S, Bilir G (2005) Ovarian cyst formation in patients using tamoxifen for breast cancer. Jpn J Clin Oncol 35(10):607–611CrossRef Metindir J, Aslan S, Bilir G (2005) Ovarian cyst formation in patients using tamoxifen for breast cancer. Jpn J Clin Oncol 35(10):607–611CrossRef
35.
go back to reference Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276–285CrossRef Clemons M, Goss P (2001) Estrogen and the risk of breast cancer. N Engl J Med 344(4):276–285CrossRef
Metadata
Title
Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study
Authors
Mathilde Gottschau
Allan Jensen
Kristian Reinholdt
Sonia Guleria
Christian Munk
Lene Mellemkjær
Susanne K. Kjær
Publication date
01-11-2019
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2019
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-019-05369-8

Other articles of this Issue 1/2019

Breast Cancer Research and Treatment 1/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine